FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...